Vascular endothelial growth factor-2578 A/C,-460 T/C and+405 G/C polymorphisms in polycystic ovary syndrome
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, vol.147, no.1, pp.57-60, 2009 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 147 Issue: 1
- Publication Date: 2009
- Doi Number: 10.1016/j.ejogrb.2009.06.026
- Journal Name: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.57-60
- Keywords: Polycystic ovary syndrome, Vascular endothelial growth factor, Polymorphism, FACTOR GENE POLYMORPHISMS, STROMAL BLOOD-FLOW, PERMEABILITY FACTOR, HYPERSTIMULATION SYNDROME, VEGF GENE, ASSOCIATION, WOMEN, SUSCEPTIBILITY, EXPRESSION, GRANULOSA
- Eskisehir Osmangazi University Affiliated: No
Abstract
Objective: Vascular endothelial growth factor (VEGF) may be involved in the physiological regulation of ovarian angiogenesis and pathogenesis of polycystic ovary syndrome (PCOS). VEGF -2578 A/C, -460 T/C and +405 G/C single nucleotide polymorphisms (SNPs) are known to be related to VEGF production.